Table 1.
The clinicopathologic characteristics of patients with DCIS treated with BCS.
| Risk Factors | n = 207 (%) |
| Age | |
| <50 years | 27 (13) |
| >50 years | 180 (87) |
| Family history | |
| No | 107 (52) |
| Yes | 15 (7) |
| Unknown | 85 (41) |
| Clinical presentation | |
| No | 194 (93.7) |
| Yes | 13 (6.3) |
| Nuclear grade | |
| 1 | 68 (32.8) |
| 2–3 | 130 (62.8) |
| Unknown | 9 (4.4) |
| Pathological tumor size | |
| <20 mm | 142 (68.5) |
| >20 mm | 62 (30) |
| Unknown | 3 (1.5) |
| Focality | |
| Unifocal | 176 (85) |
| Multifocal | 31 (15) |
| Comedonecrosis | |
| No | 90 (43.5) |
| Yes | 114 (55) |
| Unknown | 3 (1.5) |
| Estrogen receptors | |
| Positive | 154 (74.4) |
| Negative | 35 (16.9) |
| Unknown | 18 (8.7) |
| Progesterone receptors | |
| Positive | 108 (52.2) |
| Negative | 73 (35.3) |
| Unknown | 26 (12.5) |
| Final surgical resection margin | |
| >2 mm | 166 (80.2) |
| <2 mm | 40 (19.3) |
| Unknown | 1 (0.5) |
| Number of reinterventions | |
| 1 | 181 (87.5) |
| 2 | 23 (11) |
| 3 | 1 (0.5) |
| Unknown | 2 (1) |
| Radiotherapy | |
| No | 33 (15) |
| Yes | 174 (85) |
| Hormonotherapy | |
| No | 148 (71.5) |
| Yes | 59 (28.5) |